514 related articles for article (PubMed ID: 15334652)
1. The role of substance P in inflammatory disease.
O'Connor TM; O'Connell J; O'Brien DI; Goode T; Bredin CP; Shanahan F
J Cell Physiol; 2004 Nov; 201(2):167-80. PubMed ID: 15334652
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory properties of substance P: the gastrointestinal system as a model.
Koon HW; Pothoulakis C
Ann N Y Acad Sci; 2006 Nov; 1088():23-40. PubMed ID: 17192554
[TBL] [Abstract][Full Text] [Related]
3. Increase in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn's disease.
Michalski CW; Autschbach F; Selvaggi F; Shi X; Di Mola FF; Roggo A; Müller MW; Di Sebastiano P; Büchler MW; Giese T; Friess H
Am J Surg; 2007 Apr; 193(4):476-81. PubMed ID: 17368292
[TBL] [Abstract][Full Text] [Related]
4. Neurokinin-1 receptor (NK-1R) expression is induced in human colonic epithelial cells by proinflammatory cytokines and mediates proliferation in response to substance P.
Goode T; O'Connor T; Hopkins A; Moriarty D; O'Sullivan GC; Collins JK; O'Donoghue D; Baird AW; O'Connell J; Shanahan F
J Cell Physiol; 2003 Oct; 197(1):30-41. PubMed ID: 12942538
[TBL] [Abstract][Full Text] [Related]
5. Observations favouring the occurrence of local production and marked effects of bombesin/gastrin-releasing peptide in the synovial tissue of the human knee joint--comparisons with substance P and the NK-1 receptor.
Grimsholm O; Rantapää-Dahlqvist S; Dalén T; Forsgren S
Neuropeptides; 2008 Apr; 42(2):133-45. PubMed ID: 18289674
[TBL] [Abstract][Full Text] [Related]
6. Rapid changes in substance P signaling and neutral endopeptidase induced by skin-scratching stimulation in mice.
Yamaoka J; Kawana S
J Dermatol Sci; 2007 Nov; 48(2):123-32. PubMed ID: 17692507
[TBL] [Abstract][Full Text] [Related]
7. Substance P receptor expression in patients with inflammatory bowel disease. Determination by three different techniques, i.e., storage phosphor autoradiography, RT-PCR and immunohistochemistry.
ter Beek WP; Biemond I; Muller ES; van den Berg M; Lamers CB
Neuropeptides; 2007 Oct; 41(5):301-6. PubMed ID: 17602742
[TBL] [Abstract][Full Text] [Related]
8. Tachykinin substance P depletion by capsaicin exacerbates inflammatory response to sidestream cigarette smoke in rats.
Sun NN; Wong SS; Keith I; Witten ML
Toxicology; 2004 Sep; 201(1-3):39-50. PubMed ID: 15297018
[TBL] [Abstract][Full Text] [Related]
9. Substance P receptor expression in human skin keratinocytes and fibroblasts.
Liu JY; Hu JH; Zhu QG; Li FQ; Sun HJ
Br J Dermatol; 2006 Oct; 155(4):657-62. PubMed ID: 16965412
[TBL] [Abstract][Full Text] [Related]
10. [Airway sensory nerve and tachykinins in asthma and COPD].
Dinh QT; Klapp BF; Fischer A
Pneumologie; 2006 Feb; 60(2):80-5. PubMed ID: 16463247
[TBL] [Abstract][Full Text] [Related]
11. The effect of substance P on nitric oxide release in a rheumatoid arthritis model.
O'Shaughnessy MC; Vetsika EK; Inglis JJ; Carleson J; Haigh R; Kidd BL; Winyard PG
Inflamm Res; 2006 Jun; 55(6):236-40. PubMed ID: 16955242
[TBL] [Abstract][Full Text] [Related]
12. Neurokinin-1 receptor activation induces reactive oxygen species and epithelial damage in allergic airway inflammation.
Springer J; Groneberg DA; Dinh QT; Quarcoo D; Hamelmann E; Braun-Dullaeus RC; Geppetti P; Anker SD; Fischer A
Clin Exp Allergy; 2007 Dec; 37(12):1788-97. PubMed ID: 17941913
[TBL] [Abstract][Full Text] [Related]
13. Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus.
Remröd C; Lonne-Rahm S; Nordlind K
Arch Dermatol Res; 2007 May; 299(2):85-91. PubMed ID: 17370082
[TBL] [Abstract][Full Text] [Related]
14. Morphine Up-regulates expression of substance P and its receptor in human blood mononuclear phagocytes and lymphocytes.
Li Y; Tian S; Douglas SD; Ho WZ
Cell Immunol; 2000 Nov; 205(2):120-7. PubMed ID: 11104584
[TBL] [Abstract][Full Text] [Related]
15. Neutral endopeptidase modulation of neurogenic inflammation in airways.
Nadel JA
Eur Respir J Suppl; 1990 Dec; 12():645s-651s. PubMed ID: 2076158
[TBL] [Abstract][Full Text] [Related]
16. A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma.
Brener S; González-Moles MA; Tostes D; Esteban F; Gil-Montoya JA; Ruiz-Avila I; Bravo M; Muñoz M
Anticancer Res; 2009 Jun; 29(6):2323-9. PubMed ID: 19528498
[TBL] [Abstract][Full Text] [Related]
17. Expression of the NK-1 receptor on islet cells and invading immune cells in the non-obese diabetic mouse.
Persson-Sjögren S; Lejon K; Holmberg D; Forsgren S
J Autoimmun; 2005 Jun; 24(4):269-79. PubMed ID: 15869864
[TBL] [Abstract][Full Text] [Related]
18. A role for substance P in arthritis?
Keeble JE; Brain SD
Neurosci Lett; 2004 May; 361(1-3):176-9. PubMed ID: 15135922
[TBL] [Abstract][Full Text] [Related]
19. A role for the substance P/NK-1 receptor complex in cell proliferation and apoptosis in oral lichen planus.
González Moles MA; Esteban F; Ruiz-Avila I; Gil Montoya JA; Brener S; Bascones-Martínez A; Muñoz M
Oral Dis; 2009 Mar; 15(2):162-9. PubMed ID: 19036058
[TBL] [Abstract][Full Text] [Related]
20. Protection from DNBS-induced colitis by the tachykinin NK(1) receptor antagonist SR140333 in rats.
Ursino MG; Vasina V; De Ponti F
Eur J Pharmacol; 2009 Jan; 603(1-3):133-7. PubMed ID: 19103194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
